SUPREMO Selective Use of Postoperative Radiotherapy after Mastectomy / NHS Scotland

Accessibility statement for the SUPREMO website

This website is run by Public Health Scotland, Scotland’s national organisation for public health.

As a new organisation formed on 1 April 2020, Public Health Scotland is reviewing its web estate – including this website – aligned to corporate strategic and transformation plans.

AbilityNet has advice on making your device easier to use if you have a disability.

How accessible this website is

This site has not yet been evaluated against WCAG 2.1 level AA.

Reporting accessibility problems with this website

If you wish to contact us about any accessibility issues you encounter on this site, please contact: phs.webmaster@phs.scot

Enforcement procedure

The Equality and Human Rights Commission (EHRC) is responsible for enforcing the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018 (the ‘accessibility regulations’). If you’re not happy with how we respond to your enquiry, contact the Equality Advisory and Support Service (EASS).

Preparation of this accessibility statement

This statement was prepared on 20 September 2020. It was last reviewed on 17 September 2020.

© SUPREMO 2010
Scottish Clinical Trials Research Unit
Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB
Site Map | Feedback | Privacy & cookies| Accessibility
NHS Lothian University of Edinburgh Public Health Scotland